LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema
ConditionLymphedema, Breast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-99
SponsorUniversity Hospital, Ghent
About this trial
Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
lymph node + breast cancer requiring dissection
Disqualifiers
previous lymphedema
BMI >35
Trial design
Design model
Parallel
Treatments tested in this trial
Axilla dissection + Lymphovenous anastomosis
Procedure/Surgerysurgical bypass between lymphatic vessel and vein
Treatment groups
80 Participants
are divided into 2 treatment groupsGroup A: Axilla dissection + Lymphevenous AnastomosisExperimental treatment 1 intervention
Group B: Standard surgeryNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
The volume via circumferential measurements: swelling < 5%
Comparing the volume of the arm at each study visit via circumferential measurements: swelling \< 5%
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov